Umoja Biopharma, Inc. — Form D

Umoja Biopharma, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-24. The offering totals $210.0M, of which $210.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (8)

NameRoleLocation
Luke S EvninDirectorSeattle, WA
Anna S FrenchDirectorSeattle, WA
Robert S GlassmanDirectorSeattle, WA
John S HamerDirectorSeattle, WA
Philip S LowDirectorSeattle, WA
Andrew M ScharenbergDirectorSeattle, WA
Irena M MelnikovaExecutive OfficerSeattle, WA
Andrew M ScharenbergExecutive OfficerSeattle, WA

More